Blistering disease associated with diffuse large B cell lymphoma but without autoantibodies
1 Bastuji Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, StevensJohnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129(1) 92 96. 2 Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta analysis: duration of first line proton pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007; 147: 553 562. 3 Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997; 41(6) 735 739. 4 Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study. J Invest Dermatol 2008; 128: 35 44. 5 Garnock Jones KP. Vonoprazan: first global approval. Drugs 2015; 75(4) 439 443.
The Journal of dermatology